ITAREPS: information technology aided relapse prevention programme in schizophrenia
Language English Country Netherlands Media print-electronic
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
17920245
DOI
10.1016/j.schres.2007.09.005
PII: S0920-9964(07)00399-4
Knihovny.cz E-resources
- MeSH
- Patient Compliance MeSH
- Antipsychotic Agents therapeutic use MeSH
- Adult MeSH
- Program Evaluation MeSH
- Outcome Assessment, Health Care MeSH
- Hospitalization MeSH
- Remote Consultation methods MeSH
- Humans MeSH
- Caregivers education psychology MeSH
- Pilot Projects MeSH
- Surveys and Questionnaires MeSH
- Program Development methods MeSH
- Schizophrenic Psychology * MeSH
- Schizophrenia diagnosis drug therapy prevention & control MeSH
- Secondary Prevention MeSH
- Telephone MeSH
- Telemedicine methods MeSH
- Treatment Outcome MeSH
- Patient Readmission MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- Antipsychotic Agents MeSH
ITAREPS presents a mobile phone-based telemedicine solution for weekly remote patient monitoring and disease management in schizophrenia and psychotic disorders in general. The programme provides health professionals with home telemonitoring via a PC-to-phone SMS platform that identifies prodromal symptoms of relapse, to enable early intervention and prevent unnecessary hospitalizations. Its web-based interface offers the authorized physician a longitudinal analysis of the dynamics and development of possible prodromes. This work presents preliminary findings from a one-year mirror-design follow-up evaluation of the programme's clinical effectiveness in 45 patients with psychotic illness. There was a statistically significant 60% decrease in the number of hospitalizations during the mean 283.3+/-111.9 days of participation in the ITAREPS, compared to the same time period before the ITAREPS entry (sign test, p<0.004). Variables significantly influencing the number of hospitalizations after the ITAREPS entry (medication compliance along with factors intrinsic to the ITAREPS, i.e. adherence to the programme and involvement of a family member) suggest a critical role of the programme in controlling the number of relapses and subsequent hospitalizations in psychosis.
References provided by Crossref.org
